Literature DB >> 11205606

Influence of HIV infection on presentation of Kaposi's sarcoma.

A Ahmed1, M S Isa, H A Garba, G D Kalayi, I Muhammad, L J Egler.   

Abstract

We report a retrospective review of 57 patients with endemic Kaposi's sarcoma (EKS) seen between 1981 and 1990 and 40 prospectively diagnosed patients with and without human immunodeficiency virus (HIV) infection seen between 1991 and 1995. In the retrospective study 52 patients were males and five were females. Their ages ranged between 15 and 62 years with a mean of 39 years.Thirty-five (61%) patients had symptoms for more than 1 year. Nodular KS was seen in 75% of the patients. In the prospective study 26 patients had EKS while 14 had AIDS associated KS (AAKS). Among the patients with EKS 24 were males and two were females. The mean duration of symptoms was 20 months. The CD4 count done on nine patients ranged between 900 and 1300 cells/mm3 and there was no mortality within 1 year of presentation. Eleven of the patients with AAKS were males and three were females. Their ages ranged between 22 months and 41 years with a mean of 26. Nine patients had symptoms for less than 6 months. Ten patients had peripheral lymphadenopathy. CD4 counts done on 11 patients ranged between 200 and 800 cells/mm3. Five patients (35%) died within 6 months of presentation. Between 1991 and 1995, 486 patients were seen with HIV infection. Patients with AAKS present with fulminant disease which seemed quickly fatal.

Entities:  

Mesh:

Year:  2001        PMID: 11205606     DOI: 10.1177/004947550103100119

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  3 in total

1.  Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania.

Authors:  Phillipo L Chalya; Fidelis Mbunda; Peter F Rambau; Hyasinta Jaka; Nestory Masalu; Mariam Mirambo; Martha F Mushi; Samuel E Kalluvya
Journal:  BMC Res Notes       Date:  2015-09-15

2.  AIDS mortality in a tertiary health institution: A four-year review.

Authors:  Mahmoud U Sani; Aminu Z Mohammed; Bappa Adamu; Shehu M Yusuf; Adamu A Samaila; Musa M Borodo
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

3.  Integrative systems control approach for reactivating Kaposi's sarcoma-associated herpesvirus (KSHV) with combinatory drugs.

Authors:  Chien-Pin Sun; Takane Usui; Fuqu Yu; Ibrahim Al-Shyoukh; Jeff Shamma; Ren Sun; Chih-Ming Ho
Journal:  Integr Biol (Camb)       Date:  2009-01       Impact factor: 2.192

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.